Biochemical recurrence after prostate cancer surgery is possible to be cured if it is localized, but if metastasis occurs, it is relatively more difficult to be cured.
There are generally two kinds of postoperative recurrence of prostate cancer, namely biochemical recurrence and clinical recurrence.
Patients with biochemical recurrence usually have no symptoms, and only have abnormally high PSA (Prostate Cancer Specific Antigen) when they are retested. Patients with clinical recurrence may have localized lymph node metastasis or lesion recurrence detected by imaging, and the patients may not necessarily have symptoms, but some of them may have pain, difficulty in urination and other manifestations.
If there are biochemical recurrence of patients, their recurrent lesions are confined to the local area and there is no metastasis, they can be controlled by continuous active monitoring and taking medication. If patients can find obvious lesions, they can be treated by surgical resection, and it is possible to achieve another cure.
However, if the patient’s recurrent lesion has already had distant metastasis, then comprehensive treatment needs to be carried out for the lesion, for example, surgery can be combined with radiotherapy and chemotherapy to control the growth of the tumor and improve the patient’s quality of life.
If prostate cancer is diagnosed as biochemical recurrence after surgery, it is recommended to cooperate with doctors in time to achieve good therapeutic effect.